CytoVeris

cytoveris.com

CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery. The probes help to improve the surgeon’s ability to ensure clean margins are attained. It also develops technology to detect molecular signatures that cancer cells create due to the way that they hijack the cellular metabolic processes and corrupt DNA and protein pathways which creates signature variations of molecules such as lipids, proteins, and metabolites that can be detected with their OncoMap system. It was formed by Alan Kersey in Farmington, Connecticut in 2018.